US 11213514
Alpha-1-adrenergic receptor agonist therapy
granted A61KA61K31/4164A61K31/704
Quick answer
US patent 11213514 (Alpha-1-adrenergic receptor agonist therapy) held by The Regents of the University of California expires Mon Dec 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jan 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/4164, A61K31/704, A61K45/06, A61P